ASX dips as retail data cools rate cut hopes, Star tanks on cash burn, and Bitcoin stumbles as China faces deflation.
Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts upgraded the stock. The analysts upgraded the Ozempic obesity drugmaker to a "buy," but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback